Management of multiple valve disease

Heart

Volumn 97, Issue 4, 2011, Pages 272-277

  Unger, Philippe ^a   Rosenhek, Raphael ^b   Dedobbeleer, Chantal ^a   Berrebi, Alain ^c   Lancellotti, Patrizio ^d  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF VIENNA   (Austria)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ERGOT DERIVATIVE;

AORTA STENOSIS; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HEART VALVE SURGERY; HUMAN; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TRICUSPID VALVE DISEASE; VALVULAR HEART DISEASE;

ADRENERGIC BETA-ANTAGONISTS; CORONARY ARTERY BYPASS; ECHOCARDIOGRAPHY, DOPPLER; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; RHEUMATIC HEART DISEASE;

EID: 79551498432     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.212282     Document Type: Review

References (46)

1. Vahanian A, Baumgartner H, Bax J, et al. Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-68.
2. Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008;52:e1-142.
3. Jamieson WR, Edwards FH, Schwartz M, et al. Risk stratification for cardiac valve replacement. National Cardiac Surgery Database. Database Committee of The Society of Thoracic Surgeons. Ann Thorac Surg 1999;67:943-51.
4. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-43.
5. Soma Raju B, Turi ZG. Rheumatic fever. In: Braunwald's Heart Disease. A textbook of Cardiovascular Medicine. 8th edn. Saunders Elsevier, Philadelphia, USA 2008:2079-103.
6. Roberts WC, Dangel JC, Bulkley BH. Nonrheumatic valvular cardiac disease: a clinico-pathologic survey of 27 different conditions causing valvular dysfunction. Cardiovasc Clin 1973;5:333-446.
7. Carlson RG, Mayfield WR, Normann S, et al. Radiation-associated valvular disease. Chest 1991;99:538-45.
8. Mihaljevic T, Byrne JG, Cohn LH, et al. Long-term results of multivalve surgery for infective multivalve endocarditis. Eur J Cardiothorac Surg 2001;20:842-6.
9. Horvath J, Fross RD, Kleiner-Fisman G, et al. Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists. Mov Disord 2004;19:656-62.
10. Erek E, Casselman FR, Vanermen H. Cardiac ochronosis: valvular heart disease with dark green discoloration of the leaflets. Tex Heart Inst J 2004;31:445-7.
11. Matsuoka R, Misugi K, Goto A, et al. Congenital heart anomalies in the trisomy 18 syndrome, with reference to congenital polyvalvular disease. Am J Med Genet 1983;14:657-68.
12. Kowal-Vern A, Bharati S, Melnyk A, et al. Congenital polyvalvular cardiac disease without chromosomal abnormalities. Pediatr Pathol Lab Med 1995;15:299-308.
13. Brauner RA, Laks H, Drinkwater DC Jr, et al. Multiple left heart obstructions (Shone's anomaly) with mitral valve involvement: long-term surgical outcome. Ann Thorac Surg 1997;64:721-9.
14. Aronow WS. Heart disease and aging. Med Clin North Am 2006;90:849-62.
15. Bhattacharyya S, Gujral DM, Toumpanakis C, et al. A stepwise approach to the management of metastatic midgut carcinoid tumor. Nat Rev Clin Oncol 2009;6:429-33.
16. Balik M, Pachl J, Hendl J. Effect of the degree of tricuspid regurgitation on cardiac output measurements by thermodilution. Intensive Care Med 2002;28:1117-21.
17. Alsoufi B, Rao V, Borger MA, et al. Short- and long-term results of triple valve surgery in the modern era. Ann Thorac Surg 2006;81:2172-8.
18. Mueller XM, Tevaearai HT, Ruchat P, et al. Perioperative morbidity and mortality in combined aortic and mitral valve surgery. J Heart Valve Dis 1997;6:387-94.
19. Society of Thoracic Surgeon Adult Cardiovascular Surgery Database, 2005. http://sts. org/documents/pdf/Spring2005STS-ExecutiveSummary.pdf.
20. Mueller XM, Tevaearai HT, Stumpe F, et al. Long-term results of mitral-aortic valve operations. J Thorac Cardiovasc Surg 1998;115:1298-302.
21. Turina J, Stark T, Seifert B, et al. Predictors of the long-term outcome after combined aortic and mitral valve surgery. Circulation 1999;100(Suppl 19):II48-53.
22. Unger P, Dedobbeleer C, Van Camp G, et al. Mitral regurgitation in patients with aortic stenosis undergoing valve replacement. Heart 2010;96:9-14.
23. Connolly HM, Oh JK, Orszulak TA, et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction: prognostic indicators. Circulation 1997;95:2395-400.
24. Unger P, Magne J, Vanden Eynden F, et al. Impact of prosthesis-patient mismatch on mitral regurgitation after aortic valve replacement. Heart 2010;96:1627-32.
25. Unger P, Plein D, Van Camp G, et al. Effects of valve replacement for aortic stenosis on mitral regurgitation. Am J Cardiol 2008;102:1378-82.
26. Gillinov AM, Blackstone EH, Cosgrove DM 3rd, et al. Mitral valve repair with aortic valve replacement is superior to double valve replacement. J Thorac Cardiovasc Surg 2003;125:1372-87.
27. Smith WT, Ferguson TB Jr, Ryan T, et al. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J Am Coll Cardiol 2004;44:1241-7.
28. Pereira JJ, Balaban K, Lauer MS, et al. Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery. Am J Med 2005;118:735-42.
29. Gillinov AM, Garcia MJ. When is concomitant aortic valve replacement indicated in patients with mild to moderate stenosis undergoing coronary revascularization? Curr Cardiol Rep 2005;7:101-4.
30. Sareyyupoglu B, Sundt TM 3rd, Schaff HV, et al. Management of mild aortic stenosis at the time of coronary artery bypass surgery: should the valve be replaced? Ann Thorac Surg 2009;88:1224-31.
31. Niles N, Borer JS, Kamen M, et al. Preoperative left and right ventricular performance in combined aortic and mitral regurgitation and comparison with isolated aortic or mitral regurgitation. Am J Cardiol 1990;65:1372-8. (Pubitemid 20172507)
32. Zitnik RS, Piemme TE, Messer RJ, et al. the masking of aortic stenosis by mitral stenosis. Am Heart J 1965;69:22-30.
33. Segal J, Harvey WP, Hufnagel C. A clinical study of one hundred cases of severe aortic insufficiency. Am J Med 1956;21:200-10.
34. Cohn LH, Mason DT, Ross J Jr, et al. Preoperative assessment of aortic regurgitation in patients with mitral valve disease. Am J Cardiol.1967;19:177- 82.
35. Nakatani S, Masuyama T, Kodama K, et al. Value and limitations of Doppler echocardiography in the quantification of stenotic mitral valve area: comparison of the pressure half-time and the continuity equation methods. Circulation 1988;77:78-85.
36. Flachskampf FA, Weyman AE, Gillam L, et al. Aortic regurgitation shortens Doppler pressure half-time in mitral stenosis: clinical evidence, in vitro simulation and theoretic analysis. J Am Coll Cardiol 1990;2:396-404.
37. Gash AK, Carabello BA, Kent RL, et al. Left ventricular performance in patients with coexistent mitral stenosis and aortic insufficiency. J Am Coll Cardiol 1984;3:703-11.
38. Enriquez-Sarano M, Tajik AJ. Aortic regurgitation. N Engl J Med 2004;351:1539-46.
39. Sampat U, Varadarajan P, Turk R, et al. Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J Am Coll Cardiol 2009;54:452-7.
40. Chen CR, Cheng TO, Chen JY, et al. Percutaneous balloon mitral valvuloplasty for mitral stenosis with and without associated aortic regurgitation. Am Heart J 1993;125:128-37.
41. Cohn LH. Tricuspid regurgitation secondary to mitral valve disease: when and how to repair. J Card Surg 1994;9:237-41.
42. Colombo T, Russo C, Ciliberto GR, et al. Tricuspid regurgitation secondary to mitral valve disease: tricuspid annulus function as guide to tricuspid valve repair. Cardiovasc Surg 2001;9:369-77.
43. Dreyfus GD, Corbi PJ, Chan KM, et al. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 2005;79:127-32.
44. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004;43:405-9.
45. Skudicky D, Essop MR, Sareli P. Efficacy of mitral balloon valvotomy in reducing the severity of associated tricuspid valve regurgitation. Am J Cardiol 1994;73:209-11. (Pubitemid 24037787)
46. Bhattacharyya S, Davar J, Dreyfus G, et al. Carcinoid heart disease. Circulation 2007;116:2860-5.